Haphazard
发表于 2025-3-23 12:46:38
Hyperglycemia in Acute Strokeon is a multistep process mediated by various brain and immune cells. Inflammatory responses exaggerate the pathologies of ischemic stroke by promoting neuronal cell death and brain edema. Hyperglycemia is common in the acute stage of stroke, and this condition can promote brain inflammation and wor
故意
发表于 2025-3-23 17:18:43
Clinical Impact of Diabetes Mellitus in Cardiovascular Diseasesases. Hypertension is the most common cause of cardiovascular diseases and it is one of the most common comorbidity in diabetic patients. The risk of cardiovascular disease is higher in people with concomitant hypertension and diabetes compared to those with hypertension or diabetes alone. Diabetes
myalgia
发表于 2025-3-23 18:53:57
Epidemiology of Stroke Patients with Diabetesble the risk of stroke than those without diabetes. On the other hand, an acute stroke gives rise to abnormalities in the glucose metabolism that, in turn, affects its outcome..Diabetes mellitus can affect blood vessels in various parts of the human body. It is one of the most important risk factors
insomnia
发表于 2025-3-23 23:44:46
http://reply.papertrans.cn/88/8798/879757/879757_14.png
名词
发表于 2025-3-24 05:30:41
http://reply.papertrans.cn/88/8798/879757/879757_15.png
一再烦扰
发表于 2025-3-24 07:22:22
http://reply.papertrans.cn/88/8798/879757/879757_16.png
能量守恒
发表于 2025-3-24 14:41:34
http://reply.papertrans.cn/88/8798/879757/879757_17.png
铁塔等
发表于 2025-3-24 15:34:52
Dipeptidyl Peptidase-4 Inhibitorsat specifically bind to the catalytic domain of DPP-4, which consequently prevents the enzymatic inactivation of incretin hormones (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide). By increasing the circulating levels of active incretin hormones, DPP-4 inhibitors stimulate
BAIL
发表于 2025-3-24 22:17:12
http://reply.papertrans.cn/88/8798/879757/879757_19.png
清晰
发表于 2025-3-25 02:54:31
Glucagon-like Peptide-1 Receptor Agonistse first GLP-1RA, was approved in 2005. GLP-1 is a peptide hormone secreted by L cells of the small intestine in response to nutrients. GLP-1 presents a glucose-lowering effect via their insulinotropic action on pancreatic β-cells. In addition to their insulinotropic effect, GLP-1 also has pleiotropi